<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00874627</url>
  </required_header>
  <id_info>
    <org_study_id>K070602</org_study_id>
    <nct_id>NCT00874627</nct_id>
  </id_info>
  <brief_title>Sublingual Milk Immunotherapy in Children</brief_title>
  <acronym>Lactaide</acronym>
  <official_title>Sublingual Milk Immunotherapy in Children With IgE-mediated Cow Milk Protein Allergy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ESPCI</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sublingual immunotherapy is developing in the treatment of aeroallergens allergy. The
      hypothesis is that such process may be applied to food allergy, more precisely to milk. A
      previous series of 8 patients indicates the likely effectiveness of this technique (Allergy,
      2006).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      National study of current practice, multicentric, randomized, open All oral provocation tests
      will be randomized, double blind Study treatment. For oral provocation test, placebo with
      NeocatePasteurized half skimmed milk (available in standard outlets) from 0.1 to 0.8 mL/day
      Tests At M0 :1) Clinical examination 2) Biological test (blood sample 16.5 mL) : WBC,
      ferritin, total IgE, specific IgE, cow milk, ALPHALACTALBUMIN , casein, BETALACTOGLOBULIN and
      goat milk using RASTSpecific secretory IgA by ESPCI (frozen saliva)Biologic collection-
      Specific immunoglobulins against cow' milk, ALPHALACTALBUMIN, casein, BETALACTOGLOBULIN,
      quantification of IgM, sub classes of IgG and IgA by ESPCI (frozen serum).

      Analysis of minor allergens by immunoblot 2 D, ESPCI (frozen serum)3) prick tests 4) 1 or 2
      oral provocation test (TPO) double blind, during 2 days At M3 : clinical examination, side
      effects during the 3 preceding months At M6 :1) Clinical examination 2) Biological test
      (blood sample 16.5 mL) : WBC, ferritin, total IgE, specific IgE, cow milk, ALPHALACTALBUMIN,
      casein, BETALACTOGLOBULIN and goat milk using RAST Specific secretory IgA by ESPCI (frozen
      saliva)Biologic collection Specific immunoglobulins against cow' milk, ALPHALACTALBUMIN,
      casein, BETALACTOGLOBULIN, quantification of IgM, sub classes of IgG and IgA by ESPCI (frozen
      serum).

      Analysis of minor allergens by immunoblot 2 D, ESPCI (frozen serum)3) prick tests 4) 1 or 2
      oral provocation test (TPO) double blind, during 2 days At M12 :1) Clinical examination2)
      Biological test (blood sample 16.5 mL) : WBC, ferritin, total IgE, specific IgE, cow milk,
      ALPHALACTALBUMIN, casein, BETALACTOGLOBULIN and goat milk using RAST Specific secretory IgA
      by ESPCI (frozen saliva)Biologic collection- Specific immunoglobulins against cow' milk,
      ALPHALACTALBUMIN, casein, BETALACTOGLOBULIN , quantification of IgM, sub classes of IgG and
      IgA by ESPCI (frozen serum).

      Analysis of minor allergens by immunoblot 2 D, ESPCI (frozen serum)3) prick tests 4) 1 or 2
      oral provocation test (TPO) double blind, during 2 days
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reactive milk dose at inclusion, at 6 months and at 12 months</measure>
    <time_frame>at inclusion, at 6 months and at 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skin reaction at inclusion at 6 months and at 12 months</measure>
    <time_frame>at inclusion at 6 months and at 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specific IgE rate at inclusion, at 6 months and at 12 months</measure>
    <time_frame>at inclusion, at 6 months and at 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Cow Milk Allergy</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration of Milk</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>meals without milk</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Milk</intervention_name>
    <description>sublingual administration of milk</description>
    <arm_group_label>Experimental</arm_group_label>
    <other_name>sublingual administration of milk</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Milk</intervention_name>
    <description>placebo</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children, male and female

          -  Children &gt; 5 years

          -  Children with IgE-mediated cow milk allergy, with detectable specific IgE (&gt; 0.10
             KU/l) and an immediate type reaction during oral provocation test for a cumulated dose
             &lt; 100 mL of milk).

          -  Children and parents or tutors having given their informed consent after complete
             information

        Exclusion Criteria:

          -  Children participating or having already participated to a drug trial during the 3
             preceding months

          -  Children with immune deficiency

          -  Children with disabling disease, preventing from a correct practice of sublingual
             treatment

          -  Children receiving steroid therapy

          -  Children refusing to participateSevere food neophobia

          -  Reaction to placebo during the double blind oral provocation test

          -  Severe anaphylactic reaction with milk during the 6 preceding months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe Dupont, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Cochin - Saint-Vincent de Paul</name>
      <address>
        <city>Paris</city>
        <zip>75679</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2009</study_first_submitted>
  <study_first_submitted_qc>April 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2009</study_first_posted>
  <last_update_submitted>December 10, 2012</last_update_submitted>
  <last_update_submitted_qc>December 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>children &gt; 5 years old</keyword>
  <keyword>IgE-mediated</keyword>
  <keyword>cow milk allergy</keyword>
  <keyword>IgE-mediated cow milk allergy persisting after 5 years</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Milk Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

